[go: up one dir, main page]

GR3018685T3 - Method for the manufacture of a controlled release solid unit dosage form. - Google Patents

Method for the manufacture of a controlled release solid unit dosage form.

Info

Publication number
GR3018685T3
GR3018685T3 GR960400086T GR960400086T GR3018685T3 GR 3018685 T3 GR3018685 T3 GR 3018685T3 GR 960400086 T GR960400086 T GR 960400086T GR 960400086 T GR960400086 T GR 960400086T GR 3018685 T3 GR3018685 T3 GR 3018685T3
Authority
GR
Greece
Prior art keywords
manufacture
controlled release
dosage form
unit dosage
solid unit
Prior art date
Application number
GR960400086T
Other languages
English (en)
Inventor
Per Johan Gunnar Lundberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of GR3018685T3 publication Critical patent/GR3018685T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Control Of Vending Devices And Auxiliary Devices For Vending Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
GR960400086T 1990-12-07 1996-01-17 Method for the manufacture of a controlled release solid unit dosage form. GR3018685T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003904A SE9003904D0 (sv) 1990-12-07 1990-12-07 Method for the manufacture of a pharmaceutical dosage form
PCT/SE1991/000813 WO1992010169A1 (en) 1990-12-07 1991-12-03 Method for the manufacture of a controlled release solid unit dosage form

Publications (1)

Publication Number Publication Date
GR3018685T3 true GR3018685T3 (en) 1996-04-30

Family

ID=20381123

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400086T GR3018685T3 (en) 1990-12-07 1996-01-17 Method for the manufacture of a controlled release solid unit dosage form.

Country Status (20)

Country Link
US (1) US5419918A (el)
EP (1) EP0560822B1 (el)
JP (1) JP3239319B2 (el)
AT (1) ATE130188T1 (el)
AU (1) AU659114B2 (el)
CA (1) CA2097175A1 (el)
DE (1) DE69114721T2 (el)
DK (1) DK0560822T3 (el)
ES (1) ES2079689T3 (el)
FI (1) FI932552L (el)
GR (1) GR3018685T3 (el)
HU (1) HUT64212A (el)
IE (1) IE914229A1 (el)
IS (1) IS3789A7 (el)
NO (1) NO932054L (el)
PL (1) PL168605B1 (el)
PT (1) PT99721A (el)
SE (1) SE9003904D0 (el)
WO (1) WO1992010169A1 (el)
YU (1) YU182091A (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
AU682827B2 (en) 1992-09-18 1997-10-23 Astellas Pharma Inc. Sustained-release hydrogel preparation
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
IN186245B (el) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
JP2000034224A (ja) * 1998-05-11 2000-02-02 Freunt Ind Co Ltd 徐放性錠剤、その添加剤組成物及びそれらの製造方法
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
WO2003011256A1 (en) * 2001-07-30 2003-02-13 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition of a prokinetic agent
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
BR112015026418B1 (pt) * 2013-04-16 2022-10-04 Murray And Poole Enterprises Limited Formulação de liberação prolongada de colchicina e uso da referida formulação de liberação prolongada de colchicina
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
CA1247852A (en) * 1983-12-20 1989-01-03 Akihiko Nomura Process for preventing agglomeration of powders
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
KR910002669B1 (ko) * 1986-12-25 1991-05-03 데이산세이야꾸 가부시끼가이샤 서방성 과립 및 그를 함유하는 지속성 복합과립
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition

Also Published As

Publication number Publication date
EP0560822A1 (en) 1993-09-22
HU9301672D0 (en) 1993-09-28
EP0560822B1 (en) 1995-11-15
IE914229A1 (en) 1992-06-17
YU182091A (sh) 1994-04-05
AU659114B2 (en) 1995-05-11
WO1992010169A1 (en) 1992-06-25
NO932054D0 (no) 1993-06-04
HUT64212A (en) 1993-12-28
FI932552A0 (fi) 1993-06-04
SE9003904D0 (sv) 1990-12-07
JP3239319B2 (ja) 2001-12-17
CA2097175A1 (en) 1992-06-08
AU8930991A (en) 1992-07-08
PL299376A1 (en) 1994-03-07
PL168605B1 (pl) 1996-03-29
FI932552A7 (fi) 1993-06-04
IS3789A7 (is) 1992-06-08
NO932054L (no) 1993-06-04
JPH06503310A (ja) 1994-04-14
DE69114721D1 (de) 1995-12-21
DK0560822T3 (da) 1996-03-11
DE69114721T2 (de) 1996-04-18
ATE130188T1 (de) 1995-12-15
US5419918A (en) 1995-05-30
FI932552L (fi) 1993-06-04
PT99721A (pt) 1993-04-30
ES2079689T3 (es) 1996-01-16

Similar Documents

Publication Publication Date Title
GR3018685T3 (en) Method for the manufacture of a controlled release solid unit dosage form.
ATE260645T1 (de) Agitationsunabhängige pharmazeutische multiple- unit-retardzubereitungen und verfahren zu ihrer herstellung
DE3480705D1 (de) Gewisse 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansaeuren, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
DE69820287D1 (de) Arzneimittel, das clodronat als wirkstoff und mit siliciumdioxid behandelte mikrokristalline cellulose als füllstoff enthält
BG106927A (en) Matrix tablet for prolonged release of trimetazidine after oral administration
AU6136199A (en) Dosage form comprising therapeutic formulation
ATE151764T1 (de) Neue benzopyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltenden zubereitungen
FI951357L (fi) Farmaseuttiset koostumukset, jotka mahdollistavat trimetatsidiinin hidastetun vapautumisen oraalisen annostuksen jälkeen
ES8505379A1 (es) Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos
HU901095D0 (en) Process for producing compound reducing extraction of gastric acid and pharmaceutical preparative containing said compound
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
KR930702004A (ko) 세파로스포란 산 유도체를 함유하는 정제를 제조하기 위한 직접 압축 방법
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
ES8401947A1 (es) Procedimiento para la preparacion de (-)-2-1-(2,6-diclorofenoxi)-etil-1,3-diazaciclopent-2-eno.
EP0093497A3 (en) Anthelmintic treatment
DK93485D0 (da) Farmaceutisk praeparat til behandling af hypertension og thromboemboliske sygdomme
ZA828934B (en) Tetrazole derivatives, process for preparing these compounds, and pharmaceutical compositions thereof
HU9503696D0 (en) New compounds, their pharmaceutically acceptable salts, process for producing them and pharmaceutical compositions containing them